Mixed ligand complexes of platinum(II) and palladium(II) with cytokinin-derived compounds Bohemine and Olomoucine: X-ray structure of [Pt(BohH+-N7)Cl3]·9/5H2O {Boh=6-(benzylamino)-2-[(3-(hydroxypropyl)-amino]-9-isopropylpurine, Bohemine}

Journal of Inorganic Biochemistry

Volumn 94, Issue 4, 2003, Pages 307-316

  Trávníček, Zdeněk ^a   Maloň, Michal ^a   Zatloukal, Marek ^a   Doležal, Karel ^a   Strnad, Miroslav ^a   Marek, Jaromír ^b  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Antitumor activity; Bohemine; Olomoucine; Palladium(II); Platinum(II)

Indexed keywords

BOHEMINE PALLADIUM; BOHEMINE PLATINUM; CYCLIN DEPENDENT KINASE INHIBITOR; LIGAND; OLOMOUCINE PALLADIUM; OLOMOUCINE PLATINUM; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN MCF 7; CHRONIC MYELOID LEUKEMIA; CONDUCTANCE; CRYSTAL STRUCTURE; CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; MELANOMA; OSTEOSARCOMA; PROTON NUCLEAR MAGNETIC RESONANCE; X RAY DIFFRACTION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0346665795     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(03)00051-5     Document Type: Article

References (28)

1. Letham D.S., Palni L.M.S. Annu. Rev. Plant. Physiol. 34:1983;163-197.
2. Veselý J., Havlíček L., Strnad M., Blow J.J., Donella-Deana A., Pinna L., Letham D.S., Kato J.Y., Detivaud L., Leclerc S., Meijer L. Eur. J. Biochem. 224:1994;771-786.
3. Oh C.H., Lee S.C., Lee K.S., Woo E.R., Hong C.Y., Yang B.S., Baek D.J., Cho J.H. Arch. Pharm. Pharm. Med. Chem. 332:1999;187-190.
4. Havlíček L., Hanuš J., Veselý J., Leclerc S., Shaw G., Strnad M. J. Med. Chem. 40:1997;408-412.
5. O'Dwyer P.J., Stevenson J.P., Johnson S.W. Lippert B. Clinical Status of Cisplatin, Carboplatin, and Other Platinum-Based Antitumor Drugs, Cisplatin. Chemistry and Biochemistry of a Leading Anticancer Drug, VHCA. 1999;31-72 Wiley-VCH, Weinheim.
6. Klener P. Protinádorová Chemoterapie. 1996;318 Galén.
7. Bax A., Summers M.F. J. Am. Chem. Soc. 108:1986;2093-2094.
8. Willker W., Leibfritz D., Kerssebaum R., Bermel W. Magn. Reson. Chem. 31:1993;287-292.
9. Bodenhausen G., Ruben D.J. Chem. Phys. Lett. 69:1980;185-189.
10. Müller L. J. Am. Chem. Soc. 101:1979;4481.
11. Jeener J., Meier B.H., Bachmann P., Ernst R.R. J. Chem. Phys. 71:1979;4546.
12. Sheldrick G.M. SHELXS-97, Program For Crystal Structure Solution. 1997;University of Göttingen, Göttingen.
13. Sheldrick G.M. SHELXL-97, Program For Crystal Structure Refinement. 1997;University of Göttingen, Göttingen.
14. Trávníček Z., Maloň M., Biler M., Hajdúch M., Brož P., Doležal K., Holub J., Kryštof V., Strnad M. Transition Met. Chem. 25:2000;265-269.
15. Trávníček Z., Maloň M., Šindelář Z., Doležal K., Rolčík J., Kryštof V., Strnad M., Marek J. J. Inorg. Biochem. 84:2001;23-32.
16. Maloň M., Trávníček Z., Maryško M., Zbořil R., Mašláň M., Marek J., Doležal K., Rolčík J., Kryštof V., Strnad M. Inorg. Chim. Acta. 323:2001;119-129.
17. Geary W.J. Coord. Chem. Rev. 7:1971;81-122.
18. Pouchert C.J. The Aldrich Library of Infrared Spectra. 3rd Edition :1981;Aldrich Chemical Company Press, Milwaukee, WI.
19. Nakamoto K. Infrared and Raman Spectra of Inorganic and Coordination Compounds. 5th Edition Part B: Applications in Coordination, Organometallic, and Bioinorganic Chemistry. 1997;11 Wiley, New York.
20. D. Tarkowská, M. Kotouček, K. Doležal, Collect. Czech. Chem. Commun., in press.
21. Rochon F.D., Doyon M., Butler I.S. Inorg. Chem. 32:1993;2717-2723.
22. Tessier C., Rochon F.D. Inorg. Chim. Acta. 295:1999;25-38.
23. Terzis A. Inorg. Chem. 15:1976;793-796.
24. J. Arpalahti, K. D. Klika, S. Molander, Eur. J. Inorg. Chem. (2000) 1007-1013.
25. Iakovidis A., Hadjilidias N., Dahan F., Laussac J.-P., Lippert B. Inorg. Chim. Acta. 175:1990;57-63.
26. Lippert B., Schöllhorn H., Thewalt U. Inorg. Chim. Acta. 198-200:1992;723-732.
27. Taylor R., Kennard O. J. Mol. Struct. 78:1982;1-28.
28. Cohen P. Nat. Rev. Drug Discovery. 1:2002;309-315.